Drug Research
Digital Science welcomes Gigantum and Ripeta to the family to help increase reproducibility in research
Digital Science, a technology company serving stakeholders across the research ecosystem, welcomes two US-based startups to the Digital Science family of companies: automated reproducibility assessment tool, Ripeta, and data science platform, Gigantum. Both companies are playing...
Drug Research
HYD Pharma Develops New Deuterium-Depleted Drugs for the Treatment of Neoplastic and Metabolic Diseases
Science ignored the presence of the heavy hydrogen, deuterium (D) in living organisms for 60 years since its discovery by Harold C. Urey in the early 30’s, despite the fact, that the concentration of deuterium is 6-time higher than...
Drug Research
Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies
Biocartis Group NV , an innovative molecular diagnostics company announced the signing of a collaboration agreement with Bristol-Myers Squibb Company , a global biopharmaceutical company, aimed at the potential registration as a companion diagnostic and use of the IdyllaTM...
Articles
Implementing a more structured approach to analytical method development
The adoption of lifecycle management to ensure the quality of pharmaceutical products has been discussed extensively over recent years.
The modern concept of method lifecycle management (MLCM) provides a framework for defining the criteria and development of analytical methods, aiming...
Drug Research
Lonza’s New Spheroid-Forming Human Hepatocytes Facilitate Improved In Vitro Liver Model Systems
Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in cell culture. Researchers working in toxicology, disease...
Drug Research
Sapreme Technologies in Alliance to Develop an Oligonucleotide Delivery Platform
Sapreme Technologies, a privately-held biotech company developing a technology platform to enable the cytosolic delivery of macromolecule therapeutics, has been awarded a 6.8 M€ grant together with a multidisciplinary consortium including 11 other academic and industrial parties. ...
Drug Research
Jubilant Biosys Expands Collaboration with Sanofi in CNS Therapeutic Area
Jubilant Biosys announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area. The first collaboration with Sanofi started in 2016, to discover and develop small molecule inhibitors for multiple targets in the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read